Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Svensson, Anne-Lie
Warpman, Ulrika
Hellström-Lindahl, Ewa
Bogdanovic, Nenad
Lannfelt, Lars
and
Nordberg, Agneta
1997.
Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes.
Neuroscience Letters,
Vol. 232,
Issue. 1,
p.
37.
Lasser, Robert A.
Dukoff, Ruth
Levy, James
Levin, Robert
Lehtim�ki, Tehro
Seubert, Peter
and
Sunderland, Trey
1998.
Apolipoprotein E ?4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
International Journal of Geriatric Psychiatry,
Vol. 13,
Issue. 11,
p.
767.
V�zina, H�l�ne
Heyer, �velyne
Fortier, Isabel
Ouellette, Gail
Robitaille, Yves
and
Gauvreau, Denis
1999.
A genealogical study of Alzheimer disease in the Saguenay region of Quebec.
Genetic Epidemiology,
Vol. 16,
Issue. 4,
p.
412.
Hirono, Nobutsugu
Mori, Etsuro
Yasuda, Minoru
Imamura, Toru
Shimomura, Tatsuo
Hashimoto, Mamoru
Tanimukai, Satoshi
Kazui, Hiroaki
and
Yamashita, Hikari
1999.
Lack of Effect of Apolipoprotein E E4 Allele on Neuropsychiatric Manifestations in Alzheimer's Disease.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 11,
Issue. 1,
p.
66.
Ritchie, Karen
and
Dupuy, Anne-Marie
1999.
The current status of Apo E4 as a risk factor for Alzheimer's disease: an epidemiological perspective.
International Journal of Geriatric Psychiatry,
Vol. 14,
Issue. 9,
p.
695.
Macdonald, Angus
and
Pritchard, Delme
2000.
A Mathematical Model of Alzheimer's Disease and the Apoe Gene.
ASTIN Bulletin,
Vol. 30,
Issue. 1,
p.
69.
Høgh, Peter
Knudsen, Gitte Moos
Kjær, Karen Husted
Jørgensen, Ole Steen
Paulson, Olaf B.
and
Waldemar, Gunhild
2001.
Single Photon Emission Computed Tomography and Apolipoprotein E in Alzheimer's Disease: Impact of the ε4 Allele on Regional Cerebral Blood Flow.
Journal of Geriatric Psychiatry and Neurology,
Vol. 14,
Issue. 1,
p.
42.
Drzezga, A.
Riemenschneider, M.
Strassner, B.
Grimmer, T.
Peller, M.
Knoll, A.
Wagenpfeil, S.
Minoshima, S.
Schwaiger, M.
and
Kurz, A.
2005.
Cerebral glucose metabolism in patients with AD and different
APOE
genotypes
.
Neurology,
Vol. 64,
Issue. 1,
p.
102.
Corder, Elizabeth H.
Lannfelt, Lars
Viitanen, Matti
Corder, Larry S.
and
Winblad, Bengt
2006.
Longer Life and Healthy Aging.
Vol. 2,
Issue. ,
p.
141.
Basso, Michael
Gelernter, Joel
Yang, John
MacAvoy, Martha G.
Varma, Pradeep
Bronen, Richard A.
and
van Dyck, Christopher H.
2006.
Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
Neurobiology of Aging,
Vol. 27,
Issue. 10,
p.
1416.
Zdanys, Kristina F
Kleiman, Timothy G
MacAvoy, Martha G
Black, Benjamin T
Rightmer, Tracy E
Grey, Monique
Garman, Katherine S
Tampi, Rajesh R
Gelernter, Joel
and
van Dyck, Christopher H
2007.
Apolipoprotein E ɛ4 Allele Increases Risk for Psychotic Symptoms in Alzheimer's Disease.
Neuropsychopharmacology,
Vol. 32,
Issue. 1,
p.
171.
van der Flier, Wiesje M
Pijnenburg, Yolande AL
Fox, Nick C
and
Scheltens, Philip
2011.
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele.
The Lancet Neurology,
Vol. 10,
Issue. 3,
p.
280.
Serrano‐Pozo, Alberto
Qian, Jing
Monsell, Sarah E.
Betensky, Rebecca A.
and
Hyman, Bradley T.
2015.
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
Annals of Neurology,
Vol. 77,
Issue. 6,
p.
917.
Burns, Richard Andrew
Andrews, Shea
Cherbuin, Nicolas
and
Anstey, Kaarin Jane
2020.
Role of apolipoprotein E epsilon 4 (APOE*ε4) as an independent risk factor for incident depression over a 12-year period in cognitively intact adults across the lifespan.
BJPsych Open,
Vol. 6,
Issue. 3,
eLetters
No eLetters have been published for this article.